The warning letter follows inspections by the FDA at Dexcom’s manufacturing facilities in San Diego and Mesa, Ariz., and ...
Piper Sandler analyst Matthew O’Brien maintained a Buy rating on Dexcom (DXCM – Research Report) today and set a price target of $100.00. The ...
DexCom Inc. closed 51.77% below its 52-week high of $142.00, which the company achieved on March 26th.
Dexcom has received a warning letter from the FDA, after the agency uncovered issues during two inspections of the continuous ...
DexCom Inc. closed 50.22% short of its 52-week high of $142.00, which the company achieved on March 26th.
The company does not expect the warning letter to materially impact its manufacturing capacity, sales or ability to seek ...
DexCom received a warning letter from the Food and Drug Administration following inspections of two of its plants.
Novo Nordisk’s weight loss drug Wegovy is linked to an increased risk of hair loss, a study suggests. Meanwhile, Dexcom ...
Dexcom announced today that it received a warning letter from the FDA following inspections of two company facilities.
According to InvestingPro data, DexCom maintains strong financial health with a Piotroski score of 7, indicating robust operational efficiency. Galá’s tenure at Jazz Pharmaceuticals, a company ...